A patient with bipolar disorder is prescribed Lithium carbonate 300 mg twice daily. If the pharmacy provides 150 mg tablets, how many tablets will the patient need for one day?

Choice A reason: One tablet (37.5 mg) underdoses the prescribed 75 mg. Venlafaxine, an SNRI, modulates serotonin and norepinephrine. Scientifically, insufficient dosing fails to stabilize neural activity, risking persistent depression or anxiety symptoms, as subtherapeutic levels don’t adequately enhance neurotransmitter function, compromising treatment efficacy.

Choice B reason: Three tablets (112.5 mg) exceed the prescribed dose, risking toxicity. Venlafaxine overdosing can cause serotonin syndrome or hypertension. Scientifically, excessive SNRI dosing disrupts neurotransmitter balance, leading to adverse effects like agitation or cardiovascular issues, while precise dosing ensures safe and effective mood stabilization.

Choice C reason: Four tablets (150 mg) significantly overdose the patient, increasing toxicity risks. Venlafaxine’s effects on serotonin and norepinephrine can cause severe side effects, like seizures, if overdosed. Scientifically, maintaining therapeutic levels prevents neurological and cardiovascular complications, ensuring safe treatment for depression or anxiety.

Choice D reason: Two tablets (75 mg) match the prescribed dose, ensuring therapeutic SNRI effects. Scientifically, accurate Venlafaxine dosing optimizes serotonin and norepinephrine modulation, stabilizing mood in depression or anxiety. This prevents symptom persistence or toxicity, supporting effective neural regulation and mental health recovery without adverse effects.

Choice A reason: Prescribing medication immediately bypasses assessment, risking inappropriate treatment. Sexual violence survivors may have PTSD or anxiety, requiring tailored interventions. Scientifically, premature medication can disrupt neurotransmitter balance, potentially worsening symptoms if the underlying trauma-related neurobiological changes, like amygdala hyperactivity, aren’t first evaluated.

Choice B reason: A thorough assessment identifies trauma-related cues, like anxiety or sleep issues, guiding care. Scientifically, evaluating symptoms maps neurobiological changes, such as heightened cortisol or amygdala activity, ensuring accurate diagnosis. This informs targeted interventions, stabilizing the patient’s mental state and addressing trauma’s psychological impact effectively.

Choice C reason: Discussing therapy options before assessment is premature, as specific needs are unclear. Trauma requires tailored interventions, like CBT, based on symptom severity. Scientifically, without evaluating neurobiological impacts, like stress-induced cortisol spikes, therapy may be ineffective, delaying recovery from trauma-related disorders.

Choice D reason: Arranging a family meeting before assessment risks breaching confidentiality or causing distress. Scientifically, trauma survivors may experience heightened stress responses, like elevated cortisol, when involving family prematurely. A thorough evaluation is needed first to ensure interventions align with the patient’s psychological safety and needs.